Abe M, Shinmura Y, Tokieda Y, Mitsuhiro Y, et al. A phase I, randomized, placebo-controlled, double-blind, ascending-dose and single-center study to evaluate immunogenicity and safety of a live attenuated tetravalent dengue vaccine (KD-382) in Flavivirus antibody-naive healthy adults. Vaccine 2025;60:127313.
PMID: 40435636